Introduction to part II of the hypertension symposium. Prorenin, renal hypertension; diuretics and hyperlipidemia; angiotensin receptors and blocking drugs; a new treatment system.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000804:Angiotensin II / Q000037:antagonists & inhibitors; D057911:Angiotensin Receptor Antagonists; D000818:Animals; D004232:Diuretics / Q000009:adverse effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology; D006977:Hypertension, Renal / Q000209:etiology; D008055:Lipids / Q000097:blood; D051381:Rats; D011945:Receptors, Angiotensin; D012083:Renin / Q000097:blood
D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D004232:Diuretics; D008055:Lipids; D011945:Receptors, Angiotensin; D000804:Angiotensin II; D012083:Renin